Original Source(s)
Related Content
FDA Expands Test for Gastric and Esophageal Cancers
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
July 14, 2026
-
2 min
FDA Approves Subcutaneous Isatuximab-irfc
The approval expands subcutaneous use across newly diagnosed and previously treated multiple myeloma.
July 10, 2026
-
2 min
Spondyloarthritis function varies by sex
Women had greater functional deterioration over 17 years, while permanent work disability did not differ significantly between sexes.
August 20, 2026
-
4 min
